University of Nebraska
Omaha, Nebraska, 68022, United States
NCT Number: NCT03907384
Obesity is associated with progressive decreases in arterial health and function. It is crucial to prevent or reduce the negative effects of aging on the vasculature by implementing appropriate lifestyle interventions, such as exercise training. We examined the effects of a Mat Pilates training (MPT) regimen on arterial stiffness (pulse wave velocity, PWV), blood pressure (BP), wave reflection (AIx) and endothelial function in obese premenopausal women with elevated BP.
Looking for future studies?
Notify Me18 year–35 year
Female
Interventional
Not applicable
Omaha, Nebraska, 68022, United States
Using a parallel experimental design, participants were randomly assigned to either MPT (n=14) or non-exercising control group (n=14) for 12 weeks. Participant in the MPT group trained 3 days/week . Participants' brachial to ankle PWV (baPWV), systolic and diastolic BP, AIx, plasma NO levels were measured at baseline and after 20 weeks of their assigned intervention.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This group completed 12-weeks of training
Time frame: 12 weeks
via Pulse Wave Velocity
Time frame: 12 weeks
Automatic BP monitor
Time frame: 12 weeks
via Augmentation Index
Time frame: 12 weeks
via plasma nitric oxide
Marymount University
Other
The Effects of Mat Pilates Training on Vascular Function in Obese Premenopausal Women With Elevated Blood Pressure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03857191
Apnea, Body Weight
Grenoble, France
View Trial DetailsNCT05061173
Body Weight, Cardiovascular Diseases
Kotli, Azad Jamu Kashmir, Pakistan
View Trial DetailsNCT01684748
Body Weight, Cardiovascular Diseases
View Trial DetailsNCT01861171
Body Weight, Cardiovascular Diseases
Rio de Janeiro, Brazil
View Trial Details